NASDAQ: EIDX - Eidos Therapeutics, Inc.

Yield per half year: +178.07%
Sector: Healthcare

Eidos Therapeutics, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
 0 48.77 -100% -20.06 -100%
P/S 36595.5 33.76 108307.13%
P/BV 38.7 4.82 702.78%
P/FCF -55.23 60.98 -190.58%
Ev/Ebitda -49.6 -22.12 124.22%
Ev/S 0.0381 22.56 -99.83%
Ev/FCF -56.28 68.75 -181.86%
E/P -0.0213 0.0178 -219.84%
IP Value Score
2/10
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
 0 4.83 -100% 0 0%
ROE -70.31 9.61 -831.93%
ROA -59.27 0.3359 -17744.84%
ROIC -62.91 7.63 -924.04%
ROS -0.0795 -25.17 -99.68%
ROCE 0 15.33 -100%
IP Profitability Score
0/10
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
 -0.2 -3.67 -94.54% -0.2 0%
Nеt Debt/Ebitda 0 -3.44 -100%
Debt/Ratio 0 0.1972 -100%
Debt/Equity 0 1.65 -100%
Debt/Net Income -0.198 10.31 -101.92%
IP Debt Score
10/10
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
 0 0.5491 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5491
IP Dividend Score
0/10
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
 470270.37 -56.89 -826730.99%
Growth impulse Ebitda 5 years 0 -64.81 -100%
Growth impulse Net Income 5 years 3233.33 -58.33 -5643.17%
Growth impulse FCF 5 years 1500 -47 -3291.49%
Growth impulse EPS 5 years 1938.46 -32.41 -6081.06%
IP Growth Score
8/10
IP Score
4/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences